398 related articles for article (PubMed ID: 32818870)
1. Covalent allosteric modulation: An emerging strategy for GPCRs drug discovery.
Bian Y; Jun JJ; Cuyler J; Xie XQ
Eur J Med Chem; 2020 Nov; 206():112690. PubMed ID: 32818870
[TBL] [Abstract][Full Text] [Related]
2. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
Burford NT; Watson J; Bertekap R; Alt A
Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
[TBL] [Abstract][Full Text] [Related]
3. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
Janero DR; Thakur GA
Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
[TBL] [Abstract][Full Text] [Related]
4. Allosteric Modulators of the Class A G Protein Coupled Receptors.
Tschammer N
Adv Exp Med Biol; 2016; 917():185-207. PubMed ID: 27236557
[TBL] [Abstract][Full Text] [Related]
5. Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors.
Lindsley CW; Emmitte KA; Hopkins CR; Bridges TM; Gregory KJ; Niswender CM; Conn PJ
Chem Rev; 2016 Jun; 116(11):6707-41. PubMed ID: 26882314
[TBL] [Abstract][Full Text] [Related]
6. Bitopic Ligands and Metastable Binding Sites: Opportunities for G Protein-Coupled Receptor (GPCR) Medicinal Chemistry.
Fronik P; Gaiser BI; Sejer Pedersen D
J Med Chem; 2017 May; 60(10):4126-4134. PubMed ID: 28140580
[TBL] [Abstract][Full Text] [Related]
7. The impact of cryo-EM on determining allosteric modulator-bound structures of G protein-coupled receptors.
Zhang L; Mobbs JI; May LT; Glukhova A; Thal DM
Curr Opin Struct Biol; 2023 Apr; 79():102560. PubMed ID: 36848776
[TBL] [Abstract][Full Text] [Related]
8. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
Persechino M; Hedderich JB; Kolb P; Hilger D
Pharmacol Ther; 2022 Sep; 237():108242. PubMed ID: 35863587
[TBL] [Abstract][Full Text] [Related]
9. Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.
Wold EA; Chen J; Cunningham KA; Zhou J
J Med Chem; 2019 Jan; 62(1):88-127. PubMed ID: 30106578
[TBL] [Abstract][Full Text] [Related]
10. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
Lu S; Zhang J
J Med Chem; 2019 Jan; 62(1):24-45. PubMed ID: 29457894
[TBL] [Abstract][Full Text] [Related]
11. Molecular insights into allosteric modulation of Class C G protein-coupled receptors.
Leach K; Gregory KJ
Pharmacol Res; 2017 Feb; 116():105-118. PubMed ID: 27965032
[TBL] [Abstract][Full Text] [Related]
12. Allosteric binding sites at the receptor-lipid bilayer interface: novel targets for GPCR drug discovery.
Wang Y; Yu Z; Xiao W; Lu S; Zhang J
Drug Discov Today; 2021 Mar; 26(3):690-703. PubMed ID: 33301977
[TBL] [Abstract][Full Text] [Related]
13. High-Throughput Screening for Allosteric Modulators of GPCRs.
Bertekap RL; Burford NT; Li Z; Alt A
Methods Mol Biol; 2015; 1335():223-40. PubMed ID: 26260604
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
Grundmann M; Bender E; Schamberger J; Eitner F
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
[TBL] [Abstract][Full Text] [Related]
15. Discovery of small molecule positive allosteric modulators of the secretin receptor.
Dengler DG; Harikumar KG; Pollari S; Sun Q; Brown BT; Shinoki-Iwaya A; Ardecky R; Miller LJ; Sergienko EA
Biochem Pharmacol; 2021 Mar; 185():114451. PubMed ID: 33545115
[TBL] [Abstract][Full Text] [Related]
16. G protein-coupled receptor transmembrane binding pockets and their applications in GPCR research and drug discovery: a survey.
Kratochwil NA; Gatti-McArthur S; Hoener MC; Lindemann L; Christ AD; Green LG; Guba W; Martin RE; Malherbe P; Porter RH; Slack JP; Winnig M; Dehmlow H; Grether U; Hertel C; Narquizian R; Panousis CG; Kolczewski S; Steward L
Curr Top Med Chem; 2011; 11(15):1902-24. PubMed ID: 21470172
[TBL] [Abstract][Full Text] [Related]
17. Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery.
Slosky LM; Caron MG; Barak LS
Trends Pharmacol Sci; 2021 Apr; 42(4):283-299. PubMed ID: 33581873
[TBL] [Abstract][Full Text] [Related]
18. Current and Future Challenges in GPCR Drug Discovery.
Topiol S
Methods Mol Biol; 2018; 1705():1-21. PubMed ID: 29188556
[TBL] [Abstract][Full Text] [Related]
19. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
Bartuzi D; Kaczor AA; Matosiuk D
Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
[TBL] [Abstract][Full Text] [Related]
20. Potential for the Rational Design of Allosteric Modulators of Class C GPCRs.
Christopher JA; Doré AS; Tehan BG
Curr Top Med Chem; 2017; 17(1):71-78. PubMed ID: 27448651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
